CRIMM, Center of Research and Innovation of Myeloproliferative Neoplasms, Careggi University Hospital and Department of Experimental and Clinical Medicine, University of Florence, DENOTHE Excellence Center, Florence, Italy.
CRIMM, Center of Research and Innovation of Myeloproliferative Neoplasms, Careggi University Hospital and Department of Experimental and Clinical Medicine, University of Florence, DENOTHE Excellence Center, Florence, Italy.
Trends Genet. 2022 Jun;38(6):572-586. doi: 10.1016/j.tig.2021.11.003. Epub 2021 Dec 11.
The development of new sequencing platforms, technologies, and bioinformatics tools in the past decade fostered key discoveries in human genomics. Among the most recent sequencing technologies, nanopore sequencing (NS) has caught the interest of researchers for its intriguing potential and flexibility. This up-to-date review highlights the recent application of NS in the hematology field, focusing on progress and challenges of the technological approaches employed for the identification of pathologic alterations. The molecular and analytic pipelines developed for the analysis of the whole-genome, target regions, and transcriptomics provide a proof of evidence of the unparalleled amount of information that could be retrieved by an innovative approach based on long-read sequencing.
过去十年中,新的测序平台、技术和生物信息学工具的发展促进了人类基因组学的重大发现。在最近的测序技术中,纳米孔测序(NS)因其诱人的潜力和灵活性引起了研究人员的兴趣。本综述最新介绍了 NS 在血液学领域的应用,重点介绍了用于识别病理改变的技术方法的进展和挑战。针对全基因组、靶区和转录组分析开发的分子和分析流程为基于长读测序的创新方法可以获得的无与伦比的信息量提供了证据。